Clostridium difficile infection

WK Smits, D Lyras, DB Lacy, MH Wilcox… - Nature reviews Disease …, 2016 - nature.com
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life
threatening, especially in elderly people and in patients who have dysbiosis of the gut …

Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review

A Gupta, AN Ananthakrishnan - Therapeutic Advances in …, 2021 - journals.sagepub.com
Clostridioides difficile is the most common cause of healthcare-associated diarrhea. Disease
complications as well as recurrent infections contribute significantly to morbidity and …

[HTML][HTML] Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection

CL Hvas, SMD Jørgensen, SP Jørgensen, M Storgaard… - Gastroenterology, 2019 - Elsevier
Background & Aims Fecal microbiota transplantation (FMT) is recommended for treatment of
recurrent Clostridium difficile infection (rCDI). We performed a single-center randomized trial …

[HTML][HTML] Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK

S Manoukian, S Stewart, N Graves, H Mason… - Journal of hospital …, 2021 - Elsevier
Background Healthcare-associated infection (HAI) is associated with increased morbidity
and mortality resulting in excess costs. Aim To investigate the impact of all types of HAI on …

Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI …

SM Wingen-Heimann, K Davies, VF Viprey… - Clinical Microbiology …, 2023 - Elsevier
Objectives Clostridioides difficile infection (CDI) is one of the leading nosocomial infections
worldwide, resulting in a significantly increasing burden on the healthcare systems …

Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT)

SMD Baunwall, JF Dahlerup, JH Engberg… - Scandinavian Journal …, 2021 - Taylor & Francis
Abstract Aim: This Danish national guideline describes the treatment of adult patients with
Clostridioides (formerly Clostridium) difficile (CD) infection and the use of faecal microbiota …

Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study

DN Shah, SL Aitken, LF Barragan, S Bozorgui… - Journal of Hospital …, 2016 - Elsevier
Background Few studies have investigated the additional healthcare costs of recurrent C.
difficile infection (CDI). Aim To quantify inpatient treatment costs for CDI and length of stay …

A comprehensive study of costs associated with recurrent Clostridium difficile infection

R Rodrigues, GE Barber… - infection control & …, 2017 - cambridge.org
BACKGROUND Clostridium difficile infection (CDI) is the most common healthcare-
associated infection and is associated with considerable morbidity. Recurrent CDI is a key …

Economic burden and cost-effective management of Clostridium difficile infections

SM Heimann, MRC Aguilar, S Mellinghof… - Médecine et maladies …, 2018 - Elsevier
Clostridium difficile infection (CDI) is the most important cause of healthcare-associated
infectious diarrhea in industrialized countries. We performed a literature review of the overall …

Economic Burden of Clostridium difficile Infection in European Countries

E Reigadas Ramírez, ES Bouza - … Diseases and Public Health Volume 8, 2018 - Springer
Clostridium difficile infection (CDI) remains a considerable challenge to health care systems
worldwide. Although CDI represents a significant burden on healthcare systems in Europe …